Arkolith/Insider Trading/TCRR/Form 4

Cardama Alfonso Quintas

Chief Medical OfficerTCR2 THERAPEUTICS INC. (TCRR) · full profile →Form 4 · filed Jun 1, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
1 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2023Disposed to issuer(D)109K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 1, 2023Disposed to issuer(D)71K—$00
Jun 1, 2023Disposed to issuer(D)42K—$00
Jun 1, 2023Disposed to issuer(D)91K—$00
Jun 1, 2023Disposed to issuer(D)115K—$00
Jun 1, 2023Disposed to issuer(D)32K—$00
Jun 1, 2023Disposed to issuer(D)1K—$00
Jun 1, 2023Disposed to issuer(D)10K—$00
Jun 1, 2023Disposed to issuer(D)6K—$00
Jun 1, 2023Disposed to issuer(D)12K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-067068) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML